Literature DB >> 22817626

Controlled release of thymosin β4 from injected collagen-chitosan hydrogels promotes angiogenesis and prevents tissue loss after myocardial infarction.

Loraine L Y Chiu1, Lewis A Reis, Abdul Momen, Milica Radisic.   

Abstract

AIMS: Acute myocardial infarction (MI) leads to fibrosis and severe left ventricular wall thinning. Enhancing vascularization within the infarct reduces cell death and maintains a thick left ventricular wall, which is essential for proper cardiac function. Here, we evaluated the controlled delivery of thymosin β4 (Tβ4), which supports cardiomyocyte survival by inducing vascularization and upregulating Akt activity, in the treatment of MI. MATERIALS &
METHODS: We injected collagen-chitosan hydrogel with controlled release of Tβ4 into the infarct after performing left anterior descending artery ligation in rats.
RESULTS: Tβ4-encapsulated hydrogel (thymosin) significantly reduced tissue loss post-MI (13 ± 4%), compared with 58 ± 3% and 30 ± 8% tissue loss for no treatment (MI only) and Tβ4-free hydrogel (control). Significantly more Factor VIII-positive blood vessels with diameter >50 µm were in the thymosin group compared with both MI only and control (p < 0.0001), showing Tβ4-induced vascularization. Wall thickness was positively correlated with the mature blood vessel density (r = 0.9319; p < 0.0001).
CONCLUSION: Controlled release of Tβ4 within the infarct enhances angiogenesis and presence of cardiomyocytes that are necessary for cardiac repair.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817626     DOI: 10.2217/rme.12.35

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  8 in total

1.  PEG-maleimide hydrogels for protein and cell delivery in regenerative medicine.

Authors:  Andrés J García
Journal:  Ann Biomed Eng       Date:  2013-07-24       Impact factor: 3.934

Review 2.  Regenerative medicine: transforming the drug discovery and development paradigm.

Authors:  Sotirios K Karathanasis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

Review 3.  The role of tissue engineering and biomaterials in cardiac regenerative medicine.

Authors:  Yimu Zhao; Nicole T Feric; Nimalan Thavandiran; Sara S Nunes; Milica Radisic
Journal:  Can J Cardiol       Date:  2014-09-04       Impact factor: 5.223

4.  A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery.

Authors:  Aleksander Skardal; Sean V Murphy; Kathryn Crowell; David Mack; Anthony Atala; Shay Soker
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2016-06-28       Impact factor: 3.405

5.  Biowire Model of Interstitial and Focal Cardiac Fibrosis.

Authors:  Erika Yan Wang; Naimeh Rafatian; Yimu Zhao; Angela Lee; Benjamin Fook Lun Lai; Rick Xingze Lu; Danica Jekic; Locke Davenport Huyer; Ericka J Knee-Walden; Shoumo Bhattacharya; Peter H Backx; Milica Radisic
Journal:  ACS Cent Sci       Date:  2019-06-04       Impact factor: 14.553

6.  Injectable collagen scaffold promotes swine myocardial infarction recovery by long-term local retention of transplanted human umbilical cord mesenchymal stem cells.

Authors:  Qiang Wang; Xiaojun He; Bin Wang; Jun Pan; Chunying Shi; Jie Li; Liudi Wang; Yannan Zhao; Jianwu Dai; Dongjin Wang
Journal:  Sci China Life Sci       Date:  2020-07-23       Impact factor: 6.038

Review 7.  In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'.

Authors:  Isaac Perea-Gil; Cristina Prat-Vidal; Antoni Bayes-Genis
Journal:  Stem Cell Res Ther       Date:  2015-12-06       Impact factor: 6.832

Review 8.  Peptide-Based Functional Biomaterials for Soft-Tissue Repair.

Authors:  Katsuhiro Hosoyama; Caitlin Lazurko; Marcelo Muñoz; Christopher D McTiernan; Emilio I Alarcon
Journal:  Front Bioeng Biotechnol       Date:  2019-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.